News Archive

IMN’s Virtual Investors’ Conference on BioHealth, taking place November 18, will provide a platform to understand the intersection of securitization across the biotech and healthcare sector, helping educate investors, borrowers and industry participants on the hottest new asset class in equity capital markets. This one-day virtual conference will focus on both on European and U.S. opportunities and challenges, as regulatory challenges will be forefront on both sides of the globe. 

BioHealth issuance in 2020 has now surpassed $60 billion globally, spurring this asset class to become the second most popular equity capital markets sector, with momentum driven by huge secondary moves and companies benefitting from a greater focus on healthcare investing that Covid-19 has generated.  

Join this must-attend gathering to engage with hedge funds, institutional investors, and more, to discover exciting new investment opportunities as this sector expands to comply with policy, market demand and changing consumer needs.

Montgomery County Economic Development Corporation (MCEDC)  President and CEO  Benjamin Wu Chats with Rich Bendis on BioTalk.

Listen now Apple https://apple.co/2SJB2a5, Google https://bit.ly/2SMLbmd, Spotify https://spoti.fi/34SWcrI, https://bit.ly/2SMde5j, and YouTube Audio https://bit.ly/2GSHXeu

As the President and Chief Executive Officer of MCEDC, Ben Wu leads the public-private economic development of Maryland’s largest jurisdiction which comprises 25% of the state’s economy with a GDP greater than 13 states. A Montgomery County native, Ben is an accomplished executive with over three decades of professional experience leading operations at the highest levels of our nation and state.

Join fellow biotech leaders and is presented by the Association of University Research Parks, AstraZeneca, BioHealth Innovation, Children’s National Health System, Emergent BioSolutions, George Mason University, J.P. Morgan, Johns Hopkins University, Maryland Department of Commerce, Virginia Bio, and Wilson Sonsini Goodrich & Rosati, P.C.

Maryland, Virginia, and Washington, DC set the bar high for biotech innovation. So please join us for our 6th Annual BioHealth Capital Region Forum that will highlight the accomplishments of today and chart our successes of tomorrow.

We are excited to bring you an exceptional line up of more than 55 BioHealth Capital Region industry leaders to this virtual event!

American Gene Technologies International Inc. (AGT) CEO and Founder, Jeff Galvin returns to update us of their Phase 1 Clinical Trial of their lead #HIV Program, their expansion in a new facility, and what’s next!

Listen now on Apple https://apple.co/2Gi2GIF, Google https://bit.ly/2GizVvu, Spotify https://spoti.fi/2GxROGd, and TuneIn https://bit.ly/3l9HK56.

The National Institute of Standards and Technology (NIST) has selected 19 small businesses to develop new technologies through grants totaling over $4.4 million in value. The awardees will address various technology needs under phases one and two of the agency’s Small Business Innovation Research (SBIR) program, NIST said Thursday.